Fraunhofer Institute for Toxicology and Experimental Medicine

A successful step in COPD research

The results of an innovative clinical study have proven a significantly positive effect on the heart function of COPD patients.

more info

Official launch of the iCAIR project

German-Australian collaboration: battling infection and resistance

more info

Project EU-ToxRisk

Fraunhofer ITEM scientists will test new approach methodologies for animal-free toxicity testing and risk assessment

more info

Life science campus with a focus on translation

Formal opening of “Science Campus Braunschweig-Süd”

more info

High-Performance Center for Translational Biomedical Engineering

From basic research to clinical testing of medical devices.

more info

Some people try to breathe – but can’t

Human lung samples for studying respiratory diseases

more info

P.R.I.T.® exposure system

We offer new approaches for in-vitro testing of inhalable substances.

more info

Personalized tumor therapy

New mechanisms of early metastatic spread in breast cancer have been discovered.

more info

Fraunhofer ITEM: News

News / 24.4.2018


The aim of the platform TransPlaMed is to optimize the transfer of technology and knowledge on dedicated manufacturing processes in the field of biomedical engineering

News / 19.3.2018

Faster from the laboratory to the patient

Proof-of-Concept initiative of Fraunhofer, Helmholtz and Hochschulmedizin promotes pilot project in the health sector.

News / 22.2.2018

A successful step in COPD research

The results of an innovative clinical study have proven a significantly positive effect on the heart function of COPD patients.

News / 21.2.2018

2017 CRACK IT Challenge competition

Two Fraunhofer ITEM scientists have been awarded funding for their projects.


Fraunhofer ITEM

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Nikolai-Fuchs-Strasse 1
30625 Hannover

Phone +49 511 5350-0



EAACI 2018

At the EAACI Congress 2018 from May 26 to 30, Fraunhofer ITEM scientists will present several posters giving insights into recent research work.

Read more


ATS International Conference 2018

This year's annual conference of the American Thoracic Society (ATS) will be held from May 18 to 23 in San Diego, CA (USA). The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders.

Read more


SETAC 2018

At the SETAC Europe Annual Meeting in Rome (Italy) from May 13 to 17, 2018, Fraunhofer ITEM scientists will give insights into recent research work in oral and poster presentations.

Read more



On April 22, 2018, Fraunhofer ITEM scientist Dr. Sabine Wronski will present her recent research work at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Madrid, Spain.

Read more

Our services and expertise


Drug Development

From drug candidate to proof of concept


Chemical Safety and Assessment

From risk analysis towards safe products


Translational Biomedical Engineering

From idea to safe medical device


Personalized Tumor Therapy

From molecular analysis to personalized therapy

About Fraunhofer ITEM

The Fraunhofer-Institute for Toxicology and Experimental Medicine ITEM is one of 69 institutions of the Fraunhofer-Gesellschaft, Europe's leading organization for applied research. Fraunhofer ITEM aims to protect man from health hazards in our industrialized world and to contribute to the development of novel therapeutic approaches, with a focus on airway research.
With a staff of approximately 300 at its locations in Hannover, Braunschweig and Regensburg, the institute cooperates with industry, service providers, and public authorities in projects that drive economic development and serve the wider benefit of society.

More information about Fraunhofer ITEM